Suscribirse

Comparison of phenotypes of childhood wheeze and cough in 2 independent cohorts - 30/10/13

Doi : 10.1016/j.jaci.2013.08.002 
Ben D. Spycher, PhD a, , Michael Silverman, MD b, Anina M. Pescatore, MSc a, Caroline S. Beardsmore, PhD b, Claudia E. Kuehni, MD, MSc a
a Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland 
b Division of Child Health, Department of Infection, Immunity & Inflammation, University of Leicester and Institute for Lung Health, Leicester, United Kingdom 

Corresponding author: Ben D. Spycher, PhD, Institute of Social and Preventive Medicine, University of Bern, Finkenhubelweg 11, CH-3012 Bern, Switzerland.

Abstract

Background

Among children with wheeze and recurrent cough there is great variation in clinical presentation and time course of the disease. We previously distinguished 5 phenotypes of wheeze and cough in early childhood by applying latent class analysis to longitudinal data from a population-based cohort (original cohort).

Objective

To validate previously identified phenotypes of childhood cough and wheeze in an independent cohort.

Methods

We included 903 children reporting wheeze or recurrent cough from an independent population-based cohort (validation cohort). As in the original cohort, we used latent class analysis to identify phenotypes on the basis of symptoms of wheeze and cough at 2 time points (preschool and school age) and objective measurements of atopy, lung function, and airway responsiveness (school age). Prognostic outcomes (wheeze, bronchodilator use, cough apart from colds) 5 years later were compared across phenotypes.

Results

When using a 5-phenotype model, the analysis distinguished 3 phenotypes of wheeze and 2 of cough as in the original cohort. Two phenotypes were closely similar in both cohorts: Atopic persistent wheeze (persistent multiple trigger wheeze and chronic cough, atopy and reduced lung function, poor prognosis) and transient viral wheeze (early-onset transient wheeze with viral triggers, favorable prognosis). The other phenotypes differed more between cohorts. These differences might be explained by differences in age at measurements.

Conclusions

Applying the same method to 2 different cohorts, we consistently identified 2 phenotypes of wheeze (atopic persistent wheeze, transient viral wheeze), suggesting that these represent distinct disease processes. Differences found in other phenotypes suggest that the age when features are assessed is critical and should be considered carefully when defining phenotypes.

El texto completo de este artículo está disponible en PDF.

Key words : Wheeze, cough, asthma, children, phenotypes, latent class analysis, cluster analysis, cohort study, allergy, bronchial responsiveness

Abbreviations used : ALSPAC, BIC, BHR, BLRT, LCA


Esquema


 The work presented in this article was funded by Asthma UK (grant no. 07/048) and the Swiss National Science Foundation (grant no. PDFMP3-123162 and 32003B-144068). B. D. Spycher is the recipient of a European Respiratory Society/Marie Curie Joint Research Fellowship (MC 1614-2010). The research leading to these results has received funding from the European Respiratory Society and the European Community's Seventh Framework Programme FP7/2007-2013-Marie Curie Actions under grant agreement RESPIRE, PCOFUND-GA-2008-229571. Data collection has been funded by UK National Asthma Campaign, University Hospitals of Leicester NHS Trust (R&D), Leicestershire & Rutland Partnership Trust, Medisearch, Trent NHS Regional Health Authority, and the UK Department of Health.
 Disclosure of potential conflict of interest: B. D. Spycher has received grants from Swiss National Science Foundation, and the European Respiratory Society/Marie Curie Actions Joint Research Fellowship. C. S. Beardsmore and M. Silverman have received a grant from Asthma UK. C. E. Keuhni has received a grant from Swiss National Science Foundation. A. M. Pescatore declares no relevant conflicts of interest.


© 2013  American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 132 - N° 5

P. 1058-1067 - novembre 2013 Regresar al número
Artículo precedente Artículo precedente
  • The Editors' Choice
  • Donald Y.M. Leung, Stanley J. Szefler, Associate Editors of the JACI
| Artículo siguiente Artículo siguiente
  • Predictors of response to tiotropium versus salmeterol in asthmatic adults
  • Stephen P. Peters, Eugene R. Bleecker, Susan J. Kunselman, Nikolina Icitovic, Wendy C. Moore, Rodolfo Pascual, Bill T. Ameredes, Homer A. Boushey, William J. Calhoun, Mario Castro, Reuben M. Cherniack, Timothy Craig, Loren C. Denlinger, Linda L. Engle, Emily A. DiMango, Elliot Israel, Monica Kraft, Stephen C. Lazarus, Robert F. Lemanske, Njira Lugogo, Richard J. Martin, Deborah A. Meyers, Joe Ramsdell, Christine A. Sorkness, E. Rand Sutherland, Stephen I. Wasserman, Michael J. Walter, Michael E. Wechsler, Vernon M. Chinchilli, Stanley J. Szefler, National Heart, Lung, and Blood Institute's Asthma Clinical Research Network

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.